SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eiko Lifesciences gets nod to acquire 51% stake in SSM Formulations

11 Dec 2025 Evaluate

Eiko Lifesciences has secured approval to acquire 51% equity shares of M/s SSM Formulations, a company operating in business of Pharmaceuticals. The Board of Directors of the company in their meeting held on December 11, 2025 have approved the same. The board has approved the acquisition of 71,71,950 shares of SSM Formulations for a consideration of Rs 18 crore. Post acquisition, SSM Formulations will become a subsidiary of the company.

The acquisition constitutes a strategic forward integration move into pharmaceutical formulations, aimed at diversifying the product portfolio and capturing higher value across the pharmaceutical supply chain. It will consolidate company’s market position in specialty chemicals, pharmaceutical intermediates and APIs, while expanding the existing API portfolio and providing access to new niche molecules and client segments. The transaction is expected to generate operational synergies and economies of scale, and the target entity’s business aligns directly with the Company’s core line of activity.

Eiko Lifesciences is a leading manufacturer, supplier and exporter of Specialty Chemicals and Pharma Intermediates in India and Globally.

Eiko Lifesciences Share Price

49.60 -0.86 (-1.70%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×